Overview

Studies have shown that the first treatment you receive for cancer is by far the most important. On average, lung cancer patients who begin their treatment at Seattle Cancer Care Alliance (SCCA) have better survival rates than those who started treatment elsewhere.

The Lung Cancer Program at SCCA is the largest, most experienced program of its kind in the Pacific Northwest. It offers patients the latest in early detection, accurate staging as well as access to the newest treatments for lung cancer through clinical studies conducted by SCCA's physicians/researchers.

Receiving the best care as soon as possible makes all the difference when you have lung cancer or are suspected of having lung cancer. Our patients are cared for by a team of specialists, including surgeons who have special expertise in complex, minimally invasive surgeries such as video-assisted thoracic surgery (VATS); medical oncologists who specialize in targeted therapies, advanced chemotherapy treatments, tumor biology and genetic testing for smokers and non-smokers; and radiation oncologists who have special expertise in targeted radiation therapy. 

Our pulmonologists are also working on clinical studies to find better methods of detecting lung cancers at the earliest possible stages. In fact, more clinical studies take place here than anywhere else in the region. This means as a patient you have access to the newest, best treatments.